MYLAN-AMLODIPINE/ATORVASTATIN
MYLAN PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-AMLODIPINE/ATORVASTATIN in Canada?
A shortage of MYLAN-AMLODIPINE/ATORVASTATIN 5MG 40MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 28, 2026), but it has not started yet.
Why is MYLAN-AMLODIPINE/ATORVASTATIN not available?
The reason the manufacturer reported: Demand increase for the drug.
When will MYLAN-AMLODIPINE/ATORVASTATIN be available again?
The manufacturer's estimated resolution date is December 8, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02362775
Strength
5MG 40MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
AMLODIPINE ATORVASTATIN
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Demand increase for the drug.
Demand increase for the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
10MG · DIN 02257955
40MG · DIN 02257963
DIN 02388138
DIN 02388146
50MG · DIN 02468549
1G · DIN 02407302
2G · DIN 02407310
12.5MG · DIN 02554631
25MG · DIN 02247243
100MG · DIN 02247244